Tilray
A multinational cannabis, pharmaceutical, beverage, beer and consumer packaged goods company operating under the Tilray Brands name.
Last updated August 31, 2026
AI crawler reads
4requests
1companies- Anthropic4
- Profile
- 2
- Controversies
- 2
- JSON · MD
- 0
- First read
- Nov 4, 2026
- Latest read
- Nov 4, 2026
From this site's server log
Overview
Tilray is a multinational cannabis and consumer packaged goods company that developed from a Canadian medical-cannabis producer into a diversified international platform. Founded in 2013 under the umbrella of Privateer Holdings, it became one of Canada's early licensed cannabis producers and built capabilities in cultivation, processing, medical distribution, clinical research and regulated adult-use products. Its activities include medical cannabis, adult-use cannabis, hemp foods, cannabidiol-related products, alcoholic beverages, craft beer, cider and non-alcoholic drinks. The company gained unusual visibility in the cannabis sector through research and capital-market milestones. In 2014 it received an institutional investment from Founders Fund, and in 2016 it became the first cannabis company to conduct a Health Canada-approved clinical trial. Tilray received good-manufacturing-practice certification in 2017. In July 2018 it became the first cannabis company to list on a major United States stock exchange, completing an initial public offering on Nasdaq while also maintaining a Canadian market presence. The listing helped give the company access to U.S. capital markets even though federal U.S. cannabis restrictions limited direct cannabis commerce there. Tilray expanded beyond cultivation through partnerships with Sandoz, an indirect division of Novartis, and Anheuser-Busch InBev. It also created or acquired businesses in adult-use cannabis, hemp foods, cannabis research, medical distribution and retail. Its 2019 acquisition of Manitoba Harvest added a large hemp-food distribution network, while deals involving Natura Naturals, Smith & Sinclair and Four20 broadened its production, edible-product and retail capabilities. Some projects were later closed or rationalized as the company reduced costs and adjusted to difficult cannabis-market conditions. A major turning point came through the combination of Tilray and Aphria. Announced in December 2020 and completed as a reverse acquisition in December 2020, the transaction placed the combined business under the Tilray name and TLRY ticker. Aphria chief executive Irwin D. Simon became chairman and chief executive, while former Tilray chief executive Brendan Kennedy joined the board. The combination brought Aphria's cannabis operations and beverage assets together with Tilray's public-market profile, international infrastructure and European opportunities. After the Aphria transaction, the company emphasized diversification into beer and beverages, partly to create consumer brands that could operate in categories with clearer legal frameworks than cannabis. Aphria's acquisition of SweetWater Brewing Company brought a U.S. craft-beer platform into the group. In August 2023, Tilray acquired eight beverage brands and related breweries from Anheuser-Busch for $85 million, adding brands such as Blue Point, Breckenridge, Redhook, Shock Top, Widmer Brothers and HiBall Energy. Tilray's beer portfolio also includes SweetWater, Montauk, Terrapin, Green Flash, Alpine and other regional brands. The Brewers Association ranked Tilray's beer division among the largest U.S. craft brewing companies by sales volume. Tilray continues to operate across regulated cannabis markets, medical distribution and consumer packaged goods. Its medical-cannabis business has included exports from Portugal and distribution authorizations in European markets including Poland and Italy. The company remains exposed to changing cannabis laws, pricing pressure, cultivation economics, excise taxes, capital-market volatility and the performance of its beer and beverage acquisitions. Its strategic identity is therefore broader than that of a cannabis cultivator: it presents itself as a global cannabis-lifestyle and consumer-products company with a substantial beverage platform.
History
Tilray was founded in 2013 within Privateer Holdings and became one of Canada's early federally licensed cannabis producers. Its early business centered on medical cannabis cultivation, processing and distribution, supported by an effort to establish pharmaceutical-quality production and evidence-based research. In late 2014, Founders Fund provided what was described as the cannabis industry's first institutional investment. Tilray later expanded its research credentials: in 2016 it conducted a clinical trial approved by Health Canada, and in 2017 it obtained good-manufacturing-practice certification. The company pursued international medical-cannabis opportunities while Canadian adult-use legalization was approaching. In June 2018 it introduced High Park as an adult-use cannabis platform. In July of that year Tilray completed a Nasdaq initial public offering, becoming the first cannabis company to trade publicly on a major U.S. exchange. The IPO raised US$153 million. The company's share price experienced extreme volatility after listing, illustrating both investor enthusiasm for the emerging cannabis sector and the risks of speculative valuation. In September 2018 Tilray legally exported medical cannabis to the United States for a clinical trial, an important but narrowly permitted transaction under the regulatory environment then in force. Tilray also sought pharmaceutical and consumer-brand partnerships. In December 2018 it announced an alliance with Sandoz to sell, distribute and co-brand non-smokable medical-cannabis products in jurisdictions where such products were legal. The company separately entered a joint venture with Labatt Breweries, an Anheuser-Busch InBev subsidiary, to research beverages containing non-alcoholic THC or CBD. In 2019 Tilray entered a revenue-sharing arrangement with Authentic Brands Group to explore products using ABG-associated brand names. That year it acquired Manitoba Harvest for $317 million, gaining a substantial hemp-food business and retail distribution network in the United States and Canada. It also expanded through arrangements involving Natura Naturals, Smith & Sinclair and Four20, although the Natura-related High Park Gardens facility was closed in 2020 as part of cost reduction. Medical research remained a recurring part of Tilray's development. The company supplied products or participated in studies involving chemotherapy side effects, pediatric epilepsy, post-traumatic stress disorder and glioblastoma, working with academic and clinical partners in Canada, Australia, Spain and the United States. Tilray also developed European supply channels. In 2019 it agreed to export medical cannabis from its Portuguese operation to Germany, and later obtained authorization to import and distribute THC25 medical cannabis in Poland and Italy. The company's defining corporate event was its combination with Aphria. The transaction was announced on December 15, 2020, and completed as a reverse acquisition later that month. The combined company retained the Tilray name and TLRY ticker, with Aphria's Irwin D. Simon becoming chairman and chief executive. The merger joined Tilray's international and public-market assets with Aphria's cannabis operations, consumer brands and beverage interests. It also placed SweetWater Brewing Company, acquired by Aphria in 2020, within the enlarged group. Tilray subsequently made beverage diversification a central strategic theme. In 2023 it agreed to acquire eight beverage brands and breweries from Anheuser-Busch for $85 million. The portfolio included established regional beer brands such as Blue Point, Breckenridge, Redhook, Shock Top and Widmer Brothers, as well as HiBall Energy. Tilray also owns or controls other brewing operations, including SweetWater, Montauk, Terrapin and Green Flash-related assets. This expansion made Tilray one of the more significant craft-beer owners in the United States by volume while giving it consumer-packaged-goods revenue outside cannabis. Tilray's present business combines cannabis cultivation and branded products, medical distribution, international research and consumer goods. The company operates in a heavily regulated environment and must manage differences among national cannabis regimes, restrictions on cross-border trade, wholesale pricing pressure, cultivation costs and the integration of acquired beverage businesses. Its evolution from a single-category licensed producer into a cannabis, beer and consumer-products group is the central theme of its corporate history.
- 2023
Anheuser-Busch beverage portfolio acquired
[1]Tilray acquires eight beverage brands and related breweries from Anheuser-Busch for $85 million.
- 2023
Hexo acquisition agreement
[1]Tilray announces an all-share agreement to acquire Hexo.
- 2020
High Park Gardens closes
[1]Tilray announces closure of the former Natura Naturals cultivation site as part of cost reductions.
- 2020
Aphria combination completed
[1]A reverse acquisition combines Aphria and Tilray under the Tilray name and TLRY ticker.
- 2019
Manitoba Harvest acquisition
[1]Tilray acquires hemp-food producer Manitoba Harvest for $317 million.
- 2018
High Park adult-use platform launches
[1]Tilray announces High Park as a platform for adult-use cannabis brands in Canada.
- 2018
Nasdaq public listing
[1]Tilray completes a Nasdaq initial public offering and becomes the first cannabis company to trade on a major U.S. stock exchange.
- 2018
Sandoz alliance
[1]Tilray enters an arrangement with Sandoz to distribute and co-brand non-combustible medical-cannabis products in permitted markets.
- 2017
Good-manufacturing-practice certification
[1]Tilray receives certification for good manufacturing practices.
- 2016
Health Canada-approved clinical trial
[1]Tilray becomes the first cannabis company to conduct a clinical trial approved by Health Canada.
Products and positioning
A diversified international cannabis-lifestyle and consumer packaged goods company, combining regulated medical and adult-use cannabis with beer, beverages, hemp foods and wellness-oriented products.
Medical cannabis
Tilray Medical
Tilray Medical covers regulated medical-cannabis products and related distribution activities. Its portfolio has included cannabis flower, oils and other non-combustible formats supplied through legal medical channels. The business has also supported clinical research and international medical-cannabis exports, including shipments from Portugal to Germany and later distribution activity in European markets.
Adult-use cannabis · 2018
Tilray adult-use cannabis
Tilray's adult-use cannabis activities include branded flower, pre-rolls, concentrates, edibles and other products sold through regulated markets. High Park was established in 2018 as an adult-use platform in Canada. Product availability and formulation vary by province and legal market because cannabis packaging, potency, advertising and retail rules are jurisdiction-specific.
Hemp foods · 2019
Manitoba Harvest
Manitoba Harvest is a hemp-food business acquired by Tilray in 2019. Its products have included hemp hearts, protein powders, snacks and other foods made with hemp ingredients. The acquisition gave Tilray access to an established retail network in the United States and Canada and broadened its consumer-products business beyond regulated cannabis.
Craft beer · 2020
SweetWater Brewing Company
SweetWater is an Atlanta-founded craft brewery known for beers including 420 Extra Pale Ale and other hop-forward styles. Aphria acquired the brewery in 2020, shortly before its combination with Tilray. SweetWater became a cornerstone of Tilray's beverage strategy and helped establish the company as an owner of substantial U.S. craft-beer operations.
Beer and cider · 2023
Tilray beer portfolio
Tilray's beer portfolio includes regional and national craft brands such as Blue Point, Breckenridge, Redhook, Shock Top, Widmer Brothers, Montauk, Terrapin and Green Flash-related operations. The brands cover lagers, ales, India pale ales, wheat beers and other styles. The portfolio expanded substantially through the 2023 purchase of beverage assets from Anheuser-Busch.
Non-alcoholic beverages · 2023
HiBall Energy
HiBall Energy is an organic, low-sugar energy-drink brand founded in San Francisco. Anheuser-Busch discontinued the brand in 2023 before selling it to Tilray as part of the beverage-asset transaction. Tilray's ownership gives the company a non-alcoholic beverage brand alongside its beer and cannabis businesses.
Controversies
2020
Four20 sues Tilray over failed acquisition deal
Four20 filed a lawsuit seeking $130 million from Tilray and its subsidiary High Park Shop, alleging they failed to complete an agreement to acquire Four20's operations. The allegations are unproven; the article says statements of defence had not been filed.
Marketing campaigns
- 2018High Park adult-use brand platform
Canada
Tilray created High Park to develop differentiated adult-use cannabis brands ahead of Canada's recreational-cannabis market.
Outcome. The initiative established a dedicated adult-use platform within Tilray's Canadian business.
- 2018Medical cannabis research and access program
Canada · Australia · Spain · United States
Tilray supplied cannabis products for studies involving chemotherapy side effects, pediatric epilepsy, post-traumatic stress disorder and glioblastoma.
Outcome. The program supported Tilray's positioning around clinical research, although the cited material does not establish definitive therapeutic outcomes.
Brand decisions
2023
Acquire Anheuser-Busch beverage brandsM&ABackground
Tilray pursued diversification into beer and non-alcoholic beverages as cannabis markets faced regulatory and pricing constraints.
Action taken
The company agreed to acquire eight beverage brands and associated breweries from Anheuser-Busch.
Aftermath
The purchase materially expanded Tilray's U.S. craft-beer and beverage portfolio.
Acquisition price. US$85 million (August 2023)
2020
Combine with AphriaM&ABackground
The companies sought greater scale, broader geographic reach and a stronger combined platform spanning cannabis and consumer brands.
Action taken
Aphria completed a reverse acquisition of Tilray, retaining the Tilray name and TLRY ticker. Irwin D. Simon became chairman and chief executive.
Aftermath
The transaction created a larger international cannabis and consumer-products company and brought SweetWater into the combined group.
2018
Pursue a major U.S. stock-market listingStrategyBackground
Tilray sought access to U.S. capital markets while direct cannabis commerce remained constrained by federal law.
Action taken
The company completed a Nasdaq initial public offering and continued trading under the TLRY symbol.
Aftermath
The listing increased Tilray's visibility and liquidity but was followed by substantial share-price volatility.
IPO proceeds. US$153 million raised (July 2018)
Recent events
- Unconfirmed
Reported
Tilray acquires Breckenridge Distillery[4]
Tilray acquired Breckenridge Distillery, a Colorado distillery known for its whiskey and craft spirits portfolio.
- Unconfirmed
Reported
Four20 sues Tilray over failed acquisition deal[3]
Four20 filed a lawsuit seeking $130 million from Tilray and its subsidiary High Park Shop, alleging they failed to complete an agreement to acquire Four20's operations. The allegations are unproven; the article says statements of defence had not been filed.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/tilray · Editorial policy · How profiles are compiled